These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34648610)

  • 1. Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma.
    Zhu Q; Huang L; Yang Q; Ao Z; Yang R; Krzesniak J; Lou D; Hu L; Dai X; Guo F; Liu F
    Nanoscale; 2021 Oct; 13(39):16457-16464. PubMed ID: 34648610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
    Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
    Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.
    Gao M; Wu J; Zhou S; Chen Y; Wang M; He W; Jiang L; Shu Y; Wang X
    Microbiol Spectr; 2024 May; 12(5):e0401223. PubMed ID: 38497715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma.
    Chen Z; Gao Y; Huang X; Yao Y; Chen K; Zeng S; Mao W
    J Pharm Biomed Anal; 2021 Apr; 197():113937. PubMed ID: 33609949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.
    Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X
    J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
    Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
    Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
    Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
    Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.
    Yang L; Salai A; Sun X; Liu Q; Liu T; Zhang Q; Tuerxun A; Tan Y; Zheng S; Lu X
    J Proteomics; 2022 Aug; 265():104662. PubMed ID: 35728771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR and MS reveal characteristic metabolome atlas and optimize esophageal squamous cell carcinoma early detection.
    Zhao Y; Ma C; Cai R; Xin L; Li Y; Ke L; Ye W; Ouyang T; Liang J; Wu R; Lin Y
    Nat Commun; 2024 Mar; 15(1):2463. PubMed ID: 38504100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.
    Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z
    Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
    Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
    World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.
    Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L
    Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma.
    Zhao YX; Zhao HP; Zhao MY; Yu Y; Qi X; Wang JH; Lv J
    World J Gastroenterol; 2024 May; 30(20):2638-2656. PubMed ID: 38855150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Metabolic Alterations and A Predictive Marker Pipecolic Acid in Sera for Esophageal Squamous Cell Carcinoma.
    Liu L; Wu J; Shi M; Wang F; Lu H; Liu J; Chen W; Yu G; Liu D; Yang J; Luo Q; Ni Y; Jin X; Jin X; Chen WL
    Genomics Proteomics Bioinformatics; 2022 Aug; 20(4):670-687. PubMed ID: 35351627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.
    Cheng J; Zheng G; Jin H; Gao X
    Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
    Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
    J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
    Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
    Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma.
    Matsumoto Y; Kano M; Akutsu Y; Hanari N; Hoshino I; Murakami K; Usui A; Suito H; Takahashi M; Otsuka R; Xin H; Komatsu A; Iida K; Matsubara H
    Oncol Rep; 2016 Nov; 36(5):2535-2543. PubMed ID: 27599779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
    Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
    Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
    Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
    Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.